Company: MDCXW
Filing Date: 2025-01-13
Form Type: SCHEDULE 13G
Source: 0001214659-25-000501
Chunk: 0

Company: Medicus Pharma Ltd.
Filing Date: 2025-01-13
Form: SCHEDULE 13G
Chunk 0
---
,721 Common Shares outstanding as of September 30, 2024 as reported in the Company's Management's Discussion and Analysis of Results of Operations and Financial Condition filed as Exhibit 99.1 to the Company's Form 6-K filed on November 25, 2024.

| SCHEDULE 13G |

| CUSIP No. | 58471K202 |

| 1                                                                  |                                                         215 Capital Togo PHL Fund I, LP |
| 2                                                                  |                                                                                   -a)(b |
| 3                                                                  |                                                                            Sec Use Only |
| 4                                                                  |                                                                                DELAWARE |
| Number of Shares Beneficially Owned by Each Reporting Person With: |                                                                       5  2,000,000.00   
                                                                       6          0.00   
                                                                       7  2,000,000.00   
                                                                         8          0.00 |
| 9                                                                  |                                                                            2,000,000.00 |
| 10                                                                 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions) |
| 11                                                                 |                                                                                  16.9 % |
| 12                                                                 |                                                                                      PN |

Comment for Type of Reporting Person:(1) Consists of 2,000,000 the Common Shares of the Company held of record by 215 Capital Togo PHL Fund I, LP ("215 Capital"). The Management Company has been delegated the responsibilities of the general partner of 215 Capital, Togo PHL Fund I GP, LLC, including the voting and dispositive power over the shares reported herein. Mr. Ajay Raju is responsible for managing the affairs of the Management Company including the voting and dispositive power over the shares reported herein. Mr. Raju therefore may be deemed to have voting and dispositive power over the shares reported herein. (2) Based on 11,816,721 Common Shares outstanding as of September 30, 2024 as reported in the Company's Management's Discussion and Analysis of Results of Operations and Financial Condition filed as Exhibit 99.1 to the Company's Form 6-K filed on November 25, 2024.

| SCHEDULE 13G |

| CUSIP No. | 58471K202 |

| 1                                                                  |                                                                 Togo PHL Management LLC |
| 2                                                                  |                                                                                   -a)(b |
| 3                                                                  |                                                                            Sec Use Only |
| 4                                                                  |                                                                                DELAWARE |
| Number